This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,307 Years Active: 2001
Title: Axel Baur: Innovator in Mistletoe Lectin Research
Introduction
Axel Baur is a notable inventor based in Germany, recognized for his contributions to the field of biotechnology. His work primarily focuses on the development of recombinant proteins, particularly those derived from mistletoe lectin. Despite having no patents registered under his name, his research has significant implications for therapeutic applications.
Latest Patents
Axel Baur's most notable invention is related to recombinant mistletoe lectin. This invention encompasses nucleic acid molecules that encode preproproteins, which, after maturation, exhibit the biological activity of the mistletoe lectin dimer. The invention also includes vectors containing these nucleic acid molecules, transformed hosts, and the polypeptides or polypeptide dimers encoded by these molecules. The therapeutic potential of these polypeptides is vast, leading to the development of immunotoxins and pharmaceutical compositions that utilize them. Additionally, the invention covers diagnostic compositions that incorporate the nucleic acid molecules, polypeptides, and specific primers for hybridization. Furthermore, it includes plant protective agents that utilize the polypeptides and polypeptide dimers.
Career Highlights
Axel Baur is currently associated with Viscum AG, a company that focuses on innovative solutions in the field of biotechnology. His work at Viscum AG has allowed him to explore the therapeutic applications of mistletoe lectin, contributing to advancements in medical and agricultural fields.
Collaborations
Axel Baur has collaborated with notable colleagues such as Hans Lentzen and Jurgen Eck. Their combined expertise has fostered a productive research environment, leading to significant advancements in their respective fields.
Conclusion
Axel Baur's innovative work in recombinant mistletoe lectin research highlights the potential of biotechnology in therapeutic and agricultural applications. His contributions, although not yet patented, pave the way for future developments in this important area of study.